TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks

Why KP Tissue Inc stock is tanking today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:KPT.TO

Get KPT alerts:

Photos provided by Pexels

KP Tissue Inc's stock has taken a hit, closing down 0.38% in the latest trading session, raising concerns among investors.

In the latest trading session, KP Tissue Inc (KPT.TO) saw its stock price decline by 0.38%, closing at CA$13.23. This downturn comes despite the company’s recent announcement of a quarterly dividend and positive financial metrics, leaving investors questioning the underlying reasons for the stock's weakness.

Advertisement

KP Tissue Inc

KPT.TO

Full stock page →

KPT.TO

KP Tissue Inc

Source:WealthAwesomeWealthAwesome
$2.26 (21.44%)
120 day period
$10.54$12.07$13.61Feb 13May 12Aug 6

Market cap

$129.36M

P/E

14.3x

Div. yield

5.56%

Div. / share

$0.72

52W high

$13.61

52W low

$8.68

1W change

-0.93%

Beta

0.40

Analyst Price Targets

Based on analyst covering KPT

📈

Wall Street analysts forecast KPT stock price to rise 0.6% over the next 12 months.

Consensus

Neutral

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$12.88

+0.6% Upside

Current Price

C$12.80

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on KPT's historical volatility

HistoricalForecast68%95%
C$10.39C$12.09C$13.79C$15.50C$17.20C$18.90TodayMar 30Jun 3Aug 6Sep 18Nov 1Dec 14

30-Day Vol

15.6%

Annualized

90-Day Vol

16.1%

Annualized

Trend (90d)

+48.6%

Annualized drift

90d Mean

C$15.23

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$13.56C$12.85C$14.31
60 trading daysC$14.37C$13.32C$15.51
90 trading daysC$15.23C$13.87C$16.72

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: While KP Tissue's fundamentals appear stable, the recent stock price drop may signal investor uncertainty or market reactions to broader economic conditions.

KP Tissue Inc's stock down 0.38% in one trading day.

With a market cap of CA$131.76 million and a P/E ratio of 14.76, KP Tissue's valuation metrics suggest it remains relatively affordable, but investor sentiment is crucial for recovery.

Bull case

KP Tissue's recent earnings report showed a solid increase in adjusted EBITDA, indicating that the company is operating well and may have the potential for a stock price recovery.

Bear case

The slight revenue decline and lack of significant news might have led to investor hesitation, contributing to the stock's downward movement.

Advertisement

Current Performance Overview

KP Tissue Inc's stock closed down 0.38% at CA$13.23 in the last trading session. This decline comes amidst a backdrop of stable financial performance, including a recent quarterly dividend declaration of CA$0.21 per share. However, the market's reaction suggests that investors are cautious, possibly due to the slight revenue decline reported in the company's latest earnings.

Factors Influencing Investor Sentiment

Despite showing a 14.6% year-over-year increase in adjusted EBITDA, KP Tissue's revenue dip of 0.3% may have raised red flags for investors. Additionally, the absence of significant news to catalyze a positive outlook could be contributing to the stock's recent weakness. As KP Tissue prepares for its upcoming annual meeting, shareholders will be looking for reassurances about the company's direction and growth prospects.


Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 18, 2026
Last Updated: June 18, 2026

Sponsored links

Advertisement